Jan 29 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Statement on D.H.E. 45
* Expect 2016 net revenues of approximately $1 million for D.H.E. 45, or
approximately 200 units sold
* In 2016, expect to invest about $400 million on research and development and
$1 billion in patient assistance programs
* Source text -
* Further company coverage VRX.TO